HER-2 PROTEIN OVEREXPRESSION
Clinical trials for HER-2 PROTEIN OVEREXPRESSION explained in plain language.
Never miss a new study
Get alerted when new HER-2 PROTEIN OVEREXPRESSION trials appear
Sign up with your email to follow new studies for HER-2 PROTEIN OVEREXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on sarcoma in new combo trial
Disease control Recruiting nowThis study tests whether a new type of immune cell therapy (HER2-CAR T cells) combined with drugs that boost the immune system (pembrolizumab or nivolumab) is safe for people with advanced sarcoma. About 25 participants will receive chemotherapy before the cell infusion to help t…
Matched conditions: HER-2 PROTEIN OVEREXPRESSION
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
New drug targets Hard-to-Treat cancers in major trial
Disease control Recruiting nowThis phase 2 trial is testing a drug called zanidatamab in 200 adults with advanced HER2-positive solid tumors, including breast, stomach, lung, and other cancers that have worsened after at least one prior treatment. The drug is given by IV and aims to shrink or control tumor gr…
Matched conditions: HER-2 PROTEIN OVEREXPRESSION
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC